Drugs.com
JULY 28, 2024
SUNDAY, July 28, 2024 -- Peak asthma month is upon parents as summer draws to a close, experts warn.“September is known as Asthma Peak Month because kids have returned to school, and viruses are being passed around,” said allergist Dr. Gailen Mar.
Drug Patent Watch
JULY 28, 2024
Patient advocacy groups have become increasingly influential in the pharmaceutical industry, particularly in the development of generic drugs.
Drug Patent Watch
JULY 28, 2024
The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) sets minimum standards for intellectual property protection globally, including patents […] Source
Drug Patent Watch
JULY 28, 2024
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Patent Watch
JULY 28, 2024
ALOXI (palonosetron hydrochloride) Helsinn hlthcare Patent: 7,947,725 Expiration: Jul 30, 2024 See More … For more information on how DrugPatentWatch […] Source
Drug Patent Watch
JULY 28, 2024
This chart shows the pharmaceutical companies with the most powder dosed drugs. For a different perspective, see the most popular dosage types.
Expert insights. Personalized for you.
113 
Let's personalize your content